🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Gregory P. Forlenza

University of Colorado Anschutz Medical Campus

ORCID: 0000-0003-3607-9788

Also affiliated with University of Colorado Denver

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile

9.0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings

Journal of Diabetes Science and Technology(2022)10.1177/19322968221085273

Top 2%

9.0DataRank

Top 2%282 citations

Jing Wang, David Rodbard, Michael A. Kohn, Chengdong Li, Dorian Liepmann +89 more

Papers

Driven by 13 papers — median percentile 98. Top paper: “A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings”.

A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings

Journal of Diabetes Science and Technology(2022)10.1177/19322968221085273

Top 2%

9.0DataRank

Top 2%282 citations

Jing Wang, David Rodbard, Michael A. Kohn, Chengdong Li, Dorian Liepmann +89 more

Two Years with a Tubeless Automated Insulin Delivery System: A Single-Arm Multicenter Trial in Children, Adolescents, and Adults with Type 1 Diabetes

Diabetes Technology & Therapeutics(2023)10.1089/dia.2023.0364

N/A

1.3DataRank · unranked

38 citations

Anders L. Carlson, Sue A. Brown, Gregory P. Forlenza, Bruce W. Bode, Carol J. Levy +16 more

Increasing Use of Diabetes Devices: What Do Health Care Professionals Need?

Clinical Diabetes(2023)10.2337/cd22-0092

N/A

0.625DataRank · unranked

9 citations

Tim Vigers, Halis Kaan Aktürk, Gregory P. Forlenza, Kelsey B. Huss, ANGELA J. KARAMI +8 more

Racial Disparities in Diabetes Technology Adoption and Their Association with HbA1c and Diabetic Ketoacidosis

Diabetes Metabolic Syndrome and Obesity(2023)10.2147/dmso.s416192

N/A

0.489DataRank · unranked

25 citations

Andrea Gerard Gonzalez, Viral N. Shah, Cristy Geno Rasmussen, Halis Kaan Aktürk, Laura Pyle +4 more

Coverage for Continuous Glucose Monitoring for Individuals with Type 2 Diabetes Treated with Nonintensive Therapies: An Evidence-Based Approach to Policymaking

Diabetes Technology & Therapeutics(2023)10.1089/dia.2023.0268

N/A

0DataRank · unranked

34 citations

Irl B. Hirsch, Christopher G. Parkin, Janet B. McGill, Rodolfo J. Galindo, Davida Kruger +6 more

Increased Technology Use Associated With Lower A1C in a Large Pediatric Clinical Population

Diabetes Care(2023)10.2337/dc22-2121

N/A

0DataRank · unranked

28 citations

Taylor M. Triolo, Halis Kaan Aktürk, MEGHAN E. PAULEY, Marisa Sobczak, Gregory P. Forlenza +4 more

Frequency and Causes of Nocturnal Alarms in Youth and Young Adults With Type 1 Diabetes Using a First-Generation Hybrid Closed-Loop System

Diabetes Spectrum(2023)10.2337/ds23-0003

N/A

0DataRank · unranked

9 citations

Tim Vigers, Cari Berget, Laurel H. Messer, R. Paul Wadwa, Laura Pyle +2 more

Randomized, Crossover Trial of Control-IQ Technology with a Lower Treatment Range and a Modified Meal Bolus Module in Adults, Adolescents, Children, and Preschoolers with Varying Levels of Baseline Glycemic Control

Diabetes Technology & Therapeutics(2024)10.1089/dia.2024.0501

N/A

0DataRank · unranked

5 citations

Lori M. Laffel, Halis Kaan Aktürk, Gregory P. Forlenza, Viral N. Shah, R. Paul Wadwa +10 more

Glycemic variability is associated with poor outcomes in pediatric hematopoietic stem cell transplant patients

(2020)10.22541/au.158949172.29980417

N/A

0DataRank · unranked

0 citations

Kristen Campbell, Amy K. Keating, Laura Pyle, Arthur Liu, Michael R. Verneris +3 more

Glucagon-like Peptide-1 Receptor Agonists (GLP-1-RA) and GLP-1/Gastrointestinal Peptide RA (GLP-1/GIP-RA) Use in Adolescents and Young Adults with Type 1 Diabetes and Overweight or Obesity

Diabetes Technology and Obesity Medicine(2025)10.1089/dtom.2025.0018

N/A

0DataRank · unranked

3 citations

Tyler Dobbs, Claire Zimmerman, Gregory P. Forlenza, G. Todd Alonso, Kristen J. Nadeau +1 more

Barriers to Uptake of Insulin Technologies and Novel Solutions

Medical Devices Evidence and Research(2021)10.2147/mder.s312858

N/A

0DataRank · unranked

46 citations

Cari Berget, Laurel H. Messer, Gregory P. Forlenza, MEGHAN E. PAULEY

Lost in Translation: A Disconnect Between the Science and Medicare Coverage Criteria for Continuous Subcutaneous Insulin Infusion

Diabetes Technology & Therapeutics(2021)10.1089/dia.2021.0196

N/A

0DataRank · unranked

10 citations

Christopher G. Parkin, Anders L. Carlson, Rodolfo J. Galindo, Davida Kruger, Carol J. Levy +4 more

Increase Access, Reduce Disparities: Recommendations for Modifying Medicaid CGM Coverage Eligibility Criteria

Journal of Diabetes Science and Technology(2022)10.1177/19322968221144052

N/A

0DataRank · unranked

15 citations

Grazia Aleppo, Christopher G. Parkin, David A. Baidal, Anders L. Carlson, Eda Cengiz +6 more